LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_000268.3:c.863C>G
NF2
· NP_000259.1:p.(Ser288Ter)
· NM_000268.3
GRCh37: chr22:30061031 C>G
·
GRCh38: chr22:29665042 C>G
Gene:
NF2
Transcript:
NM_000268.3
Final call
Likely Pathogenic
PVS1 very strong
PM2 supporting
Variant details
Gene
NF2
Transcript
NM_000268.3
Protein
NP_000259.1:p.(Ser288Ter)
gnomAD AF
ClinVar
Pathogenic
OncoKB
Likely Oncogenic
Classification rationale
Interpretation summary
Generated evidence synthesis
1
PVS1 (Very Strong): Nonsense p.Ser288Ter truncates merlin at 288 of 595 amino acids and is predicted to trigger nonsense-mediated decay.
2
PM2 (Supporting): The variant is absent from gnomAD v2.1, v4.1, and gnomAD-Canada, three large population cohorts.
3
Together, PVS1 (very strong) plus PM2 (supporting) yields Likely Pathogenic under the ClinGen SVI 2020 combination rule (posterior probability 0.988).
Final determination:
Generic ACMG/AMP 2015 fallback: PVS1 (very strong) + PM2 (supporting) = 1 very strong + 1 supporting, which is Likely Pathogenic under the ClinGen SVI 2020 PM2-downgrade addendum (PVS1 + 1 supporting criterion -> Likely Pathogenic, Post_P 0.988); the combination does not satisfy any Pathogenic rule (no 1 strong, no 2 moderate, and no 1 moderate + 1 supporting or 2 supporting alongside PVS1).
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | Met | Met (very strong): Nonsense change p.Ser288Ter truncates merlin at 288 of 595 amino acids and is predicted to trigger nonsense-mediated decay. |
pvs1_generic_framework
pvs1_gene_context
pvs1_variant_assessment
PMID:25741868
PMID:9643284
PMID:19545378
gnomad_v2
gnomad_v4
gnomad_canada
spliceai
|
| PS1 | N/A | Not applicable: as a nonsense change producing a stop codon, no altered amino acid exists to compare against a known pathogenic missense at this position. |
generic_acmg_combination_rules
|
| PS2 | Not assessed | Not assessed: no de novo occurrence report or parental genotype data were available for this variant. |
generic_acmg_combination_rules
clinvar
|
| PS3 | Not assessed | Not assessed: no validated functional assay specific to this variant was available to demonstrate a damaging effect. |
PMID:25741868
oncokb
PMID:9643284
PMID:19545378
PMID:22825583
PMID:8755919
generic_acmg_combination_rules
|
| PS4 | Not met | Not met: no case-control or cohort prevalence study exists; the only observation is a single laboratory submission, short of the multiple-unrelated-patients requirement. |
clinvar
PMID:25741868
|
| PM1 | N/A | Not applicable: no altered residue exists to evaluate, as this is a nonsense change rather than a missense variant. |
generic_acmg_combination_rules
|
| PM2 | Met | Met (supporting): absent from gnomAD v2.1, v4.1, and gnomAD-Canada, three large population cohorts, in a gene with an established loss-of-function disease mechanism. |
gnomad_v2
gnomad_v4
gnomad_canada
|
| PM3 | N/A | Not applicable: this criterion applies only to recessive disorders, and NF2-related schwannomatosis is autosomal dominant. |
PMID:25741868
PMID:19545378
|
| PM4 | N/A | Not applicable: no protein length change occurs, so this criterion for in-frame insertions/deletions or stop-loss variants does not apply. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PM5 | N/A | Not applicable: no missense change exists at this residue to compare against a previously pathogenic missense at the same position. |
generic_acmg_combination_rules
|
| PM6 | Not assessed | Not assessed: no unconfirmed de novo report or parental testing data were available for this variant. |
generic_acmg_combination_rules
clinvar
|
| PP1 | Not assessed | Not assessed: no co-segregation data in affected family members were available for this variant. |
generic_acmg_combination_rules
clinvar
|
| PP2 | N/A | Not applicable: no missense change is present, so the gene's missense-constraint properties are not relevant to this variant. |
generic_acmg_combination_rules
|
| PP3 | N/A | Not applicable: as a nonsense change, the truncating effect is established directly from the sequence; SpliceAI max delta 0.00 shows no competing splice effect. |
spliceai
bayesdel
generic_acmg_combination_rules
|
| PP4 | Not met | Not met: no proband phenotype or family-history documentation was available to establish a highly specific phenotype. |
clinvar
PMID:25741868
|
| PP5 | Not met | Not met: the only ClinVar submission is a single 1-star laboratory classification, not an expert-panel classification as this criterion requires. |
clinvar
PMID:25741868
|
| BA1 | Not met | Not met: allele frequency is zero (absent from gnomAD v2.1, v4.1, and gnomAD-Canada), far below the 5% BA1 threshold. |
gnomad_v2
gnomad_v4
gnomad_canada
|
| BS1 | Not met | Not met: allele frequency zero (absent from all three gnomAD cohorts) is far below the 0.3% BS1 threshold. |
gnomad_v2
gnomad_v4
gnomad_canada
PMID:19545378
|
| BS2 | Not met | Not met: no heterozygous or homozygous observations exist in population cohorts, so no healthy-adult carrier evidence is available. |
gnomad_v2
gnomad_v4
gnomad_canada
|
| BS3 | Not assessed | Not assessed: no functional study demonstrating preserved protein function or splicing was available for this variant. |
PMID:25741868
spliceai
oncokb
PMID:9643284
generic_acmg_combination_rules
|
| BS4 | Not assessed | Not assessed: no family genotype data were available to evaluate whether segregation is contradicted in affected relatives. |
generic_acmg_combination_rules
clinvar
|
| BP1 | N/A | Not applicable: no missense change is present, so this criterion for missense variants in genes with primarily truncating disease mechanisms does not apply. |
generic_acmg_combination_rules
|
| BP2 | Not assessed | Not assessed: no parental or family data were available to determine whether the variant lies in cis or trans with a pathogenic variant. |
clinvar
PMID:25741868
|
| BP3 | N/A | Not applicable: no in-frame insertion or deletion in a repetitive region is present to evaluate. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| BP4 | N/A | Not applicable: the nonsense change definitively impacts the gene product, and SpliceAI's no-splice-impact prediction (0.00) does not show overall benignity. |
spliceai
generic_acmg_combination_rules
|
| BP5 | Not met | Not met: no alternate genetic cause of disease was documented for this variant. |
PMID:25741868
|
| BP6 | Not met | Not met: no benign or likely-benign ClinVar assertion exists for this variant, and only expert-panel classifications qualify for this criterion. |
clinvar
PMID:25741868
|
| BP7 | N/A | Not applicable: this criterion applies only to synonymous variants, and this is a nonsense change. |
generic_acmg_combination_rules
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.